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ABstRACt
Objective: To evaluate the relationship between cases of calci-
fying tendinopathy of the shoulder and symptomatic metabolic 
diseases such as kidney stones, gallstones and gout. Methods: 
Calcifying tendinopathy of the shoulder was diagnosed in 63 
patients between May 2007 and September 2011. All the pa-
tients were treated by the same orthopedic surgeon and were 
interviewed to gather the following data: age at diagnosis, sex, 
affected side, dominant side, body mass index (BMI), smoking 
status and previous histories of kidney stones, gallstones or gout. 
For statistical analysis, a control group of 63 patients with si-
milar demographic characteristics was used. Results: Among 
the 63 patients with calcifying tendinopathy of the shoulder, 
35 (56%) were male. The right side was affected in 38 patients 
INtRODUCtION
Calcifying tendinopathy is a common disorder 
of the shoulder, of unknown etiology, characterized 
by deposition of calcium crystals inside one or more 
tendons of the rotator cuff(1). It affects around 3% of 
adults and, of these, one third start to show symptoms 
within three years. In painful shoulders, it may be 
diagnosed in around 7% of the cases. It occurs espe-
cially in female patients between the fourth and sixth 
decades of life(2,3). 
These calcifications occur with greatest frequency 
in the supraspinatus tendon (51 to 90%), followed 
by cases in the tendons of the infraspinatus and teres 
minor. The subscapularis is the least affected tendon, 
in only 3% of the cases(2,3).
Although the etiology is still not completely 
understood, it is known that deposition of calcium 
hydroxyapatite occurs in the affected tendon, with 
consequent spontaneous reabsorption and tendon 
healing(2). Tissue hypoxia and localized pressure have 
already been reported as causal factors. Two different 
processes for formation of calcium deposits have been 
proposed: degenerative and reactive calcification(4).
The degenerative hypothesis, which was propo-
sed by Codman, correlates tissue hypovascularization 
with consequent fibrosis, necrosis and local calcifi-
cation. The advocates of this theory generally do not 
take into consideration the typical age distribution of 
the patients affected, the course of the disease and 
the morphological characteristics of the calcification. 
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(60%) and the average age was 48.2 years. Thirty-one patients 
(49%) had histories involving some of the metabolic diseases in-
vestigated: 20 patients (32%) reported kidney stones, six (9.5%) 
gallstones, four (6.3%) gout and one (2%) concurrent diagnoses 
of kidney stones and gout. In the control group, eleven patients 
(17%) had histories involving some of the metabolic diseases 
investigated: six patients (9.5%) reported kidney stones, four 
(6.3%) gallstones and one (1.6 %) gout. Conclusions: The high 
frequency of nephrolithiasis in patients with calcifying tendi-
nopathy of the shoulder in our study suggests that there are 
common mechanisms in the pathophysiology of these disorders. 
Better understanding of these diseases may enable improvement 
of diagnostics and treatments.
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According to the hypothesis of reactive calcifica-
tion, the evolution of calcifying tendinopathy can be 
divided into three phases: pre-calcification, calcifica-
tion and post-calcification(4).
Some authors have also correlated calcifying tendi-
nopathy with a genetic predisposition, through higher 
levels of human leukocytic antigen A1 (HLA-A1) in the 
patients affected, in comparison with the healthy popu-
lation. This result was not found by other authors(4,5).
There are few reports in the literature on diseases 
related to calcifying tendinopathy. Harvie et al(7) re-
ported associations with certain hormonal alterations, 
such as diabetes mellitus, hypothyroidism and disor-
ders of the menstrual cycle. However, there are no 
studies in the literature correlating calcifying tendino-
pathy with metabolic diseases such as renal lithiasis, 
gallstones and gout. 
The aim of the present study was to determine the 
frequency of associations of symptomatic metabolic 
diseases with calcifying tendinopathy of the shoulder.
MAtERIALs AND MEtHODs
Between May 2007 and September 2011, 63 pa-
tients with calcifying tendinopathy of the shoulder 
were diagnosed and treated at our clinic, by the same 
orthopedic surgeon. Cases of dystrophic calcification 
associated with rotator cuff injuries were excluded, as 
were various other cases that involved periarticular 
calcifications, such as fractures and dislocations.
All the 63 patients retrospectively agreed to par-
ticipate in the study and were then asked about their 
previous history of symptomatic metabolic diseases, 
which included renal lithiasis, gallstones and gout. 
Data on age at the time of diagnosis, sex, side affec-
ted, dominant side, body mass index and smoking 
were also gathered. 
For comparative analysis on the results, a control 
group formed by 63 patients from the general ortho-
pedics outpatient clinic was used. These individuals 
presented confirmed diagnoses of some other orthope-
dic or traumatic disorder. Among these, patients with 
calcifying tendinopathy of the shoulder or diseases of 
calcifying nature in other regions, such as calcifying 
tendinopathy of the calcaneus and triceps, were ex-
cluded. In the same way as in the study group, all the 
patients in the control group agreed to participate in 
the study, and then data were gathered regarding their 
age, sex, body mass index, smoking habits and pre-
vious histories of renal lithiasis, gallstones and gout.
To make comparisons between the groups in re-
lation to the variables, the Student t test, chi-square 
test and Fisher exact test were used. P-values < 0.005 
were taken to indicate statistical significance. The 
data were organized in Excel spreadsheets and were 
analyzed using the Statistica software, version 8.0.
REsULts
Calcifying tendinopathy group
Among the 63 patients who presented calcifying 
tendinopathy of the shoulder, 35 (56%) were male. 
The right side was affected in 38 patients (60%), the 
left side in 17 (27%) and bilaterality was recorded in 
eight cases (13%).
The mean age at the time when calcifying tendino-
pathy was diagnosed was 48.2 years. The body mass 
index (BMI) of this group was calculated as 27 kg/m2. 
Among the 63 patients, 31 (49%) presented pre-
vious histories of some of the metabolic diseases un-
der investigation: 20 patients (32%) with histories of 
renal lithiasis, six (9.5%) with gallstones and four 
(6.3%) with gout. One patient (2%) presented con-
comitant diagnoses of renal lithiasis and gout. Eight 
patients (13%) reported that they were smokers. 
Control group
The control group was formed by 63 patients with 
demographic characteristics similar to those of the 
calcifying tendinopathy group. In the control group, 32 
(51%) were male. The mean age was 50.5 years. The 
mean BMI of this group was calculated as 26.1 kg/m2. 
Among these 63 patients, 11 (17%) presented pre-
vious histories of some of the metabolic diseases in-
vestigated: six patients (9.5%) with histories of renal 
lithiasis, flour (6.3%) with gallstones and one (1.6%) 
with gout. Fourteen patients (22%) reported that they 
were smokers (Tables 1 and 2).
table 1 – Results from Student’s t test.
Variable group Mean sD p
Age
Control 50.5 10.6  
Calcifying tendinopathy 48.2 9.8 0.213
Total 49.4 10.2  
BMI
Control 26.1 4.2  
Calcifying tendinopathy 27.0 5.0 0.255
Total 26.6 4.6  
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diseases were correlated with earlier development of 
tendinopathy, longer natural histories of evolution and 
greater resistance to conservative treatment.
According to the literature, nephrolithiasis is one 
of the commonest diseases of the urinary tract, with 
incidence of between 5 and 15% of the population 
and prevalence of 2 to 3% in the general popula-
tion(11,12). In our control group, we observed a pre-
valence of 9.5%, while in the group of patients with 
calcifying tendinopathy, the prevalence was 33%. 
These data were shown to be statistically significant, 
with p-value = 0.001.
The prevalence of cholelithiasis varies according 
to geographical location and the population group, 
but it has been estimated that it affects 10 to 25% of 
American adults(13,14). In Brazil, studies have repor-
ted prevalences of 3.9 to 9.3%(15,16). In our control 
group, we observed a prevalence of 6.3%, while in 
the group of patients with calcifying tendinopathy the 
prevalence was 9.5%, without statistical significance 
when compared (p > 0.005).
In a survey conducted in the United States between 
1988 and 1994, it was estimated that around 2% of the 
men over the age of 30 years and of the women over 
the age of 50 years had a diagnosis of gout. Among 
Western men, it has been calculated that 1 to 2% have 
this disease(17). In our control group, we observed that 
the prevalence of gout was 1.6%, while in the group 
of patients with calcifying tendinopathy, the preva-
lence was 6.3%, without statistical significance when 
compared (p > 0.005).
It is important to emphasize that most studies on 
the prevalence of renal lithiasis and gallstones have 
been based on ultrasound or necropsy findings, which 
include a large number of patients with these diseases 
but who were asymptomatic. In the present study, 
since we only asked the patients about their previous 
histories of symptomatic diseases, the number of 
individuals with renal lithiasis may even have been 
underestimated.
Most authors have generally agreed that females 
are more affected by calcifying tendinopathy of the 
shoulder(1,2). However, among the patients in our study, 
males accounted for 56% of the cases, although this 
finding was not statistically significant (p > 0.005).
The other variables in this study (age, BMI and 
smoking) also did not show any statistical differences 
between the groups. 
table 2 – Results from the chi-square test.
group  
Variable Control
Calcifying 
tendinopathy
total p
n % n % n %  
sex  0.592
Female 31 49.2 28 44.4 59 46.8  
male 32 50.8 35 55.6 67 53.2  
smoking  0.159
No 49 77.8 55 87.3 104 82.5  
Yes 14 22.2 8 12.7 22 17.5  
gallstones  0.510
No 59 93.7 57 90.5 116 92.1  
Yes 4 6.3 6 9.5 10 7.9  
gout  0.365*
No 62 98.4 59 93.7 121 96.0  
Yes 1 1.6 4 6.3 5 4.0  
Renal lithiasis  0.001
No 57 90.5 42 66.7 99 78.6  
Yes 6 9.5 21 33.3 27 21.4  
total 63 100 63 100 126 100  
* Result from Fisher’s exact test.
DIsCUssION
The etiology of calcifying tendinopathy remains 
unknown, as do its associations with other comor-
bidities. There are few reports in the literature on 
conditions correlated with calcifying tendinopathy. 
Harvie et al(7) reported that calcifying tendinopathy 
was associated with hormonal abnormalities and/or 
autoimmune diseases such as hypothyroidism, diabe-
tes mellitus and rheumatoid arthritis. However, there 
are no reports on association between calcifying ten-
dinopathy and the disorder examined in this study. 
The frequency of calcifying tendinopathy is signi-
ficantly higher in manual workers, in the presence of 
diabetes (25%) and in patients with kidney failure, in 
whom the prevalence may reach 50%(8-10). 
According to Harvie et al(7), from an analysis on 
102 patients with calcifying tendinopathy of the shoul-
der, approximately 65% of the patients had already 
been diagnosed previously with some type of endocri-
ne disease, while 19% were undergoing treatment for 
some type of autoimmune disease (hypothyroidism, 
rheumatoid arthritis or diabetes mellitus). Among the 
women, 68% had already undergone some type of 
treatment for menstrual disorders. All these rates were 
significantly higher than in the general population. 
Moreover, these authors reported that the cases of 
calcifying tendinopathy associated with endocrine 
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CONCLUsION
Although the etiology of calcifying tendinopathy 
remains unknown, we believe that reports on its 
associations with other comorbidities may help 
towards understanding the disease. We noted that 
there was a high and significant association between 
calcifying tendinopathy of the shoulder and renal 
lithiasis, given that we found renal lithiasis in 33% 
of the individuals with calcifying tendinopathy of 
the shoulder, while the prevalence of renal lithiasis 
among the control group individuals was 9%. Thus, 
we believe that there may be mechanisms in common 
in the physiopathology of these disorders.
Our line of research should be continued to 
include an even larger number of patients and 
a more detailed study on the physiopathology of 
calcifying tendinopathy and renal lithiasis, in an 
attempt to create new perspectives for prevention, 
diagnosis and treatment of calcifying tendinopathy 
of the shoulder.
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